Mechanisms of Vascular Calcification: The Pivotal Role of Pyruvate Dehydrogenase Kinase 4

被引:33
作者
Leem, Jaechan [1 ]
Lee, In-Kyu [2 ,3 ]
机构
[1] Catholic Univ Dacgu, Sch Med, Dept Immunol, Daegu, South Korea
[2] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Div Endocrinol & Metabolism, Daegu, South Korea
[3] Kyungpook Natl Univ, PLUS KNU Biomed Convergence Program BK21, Daegu, South Korea
基金
新加坡国家研究基金会;
关键词
Vascular calcification; Vascular smooth muscle cells; Pyruvate dehydrogenase kinase 4; Bone morphogenetic proteins; Osteogenic differentiation; Mitochondria;
D O I
10.3803/EnM.2016.31.1.52
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Vascular calcification, abnormal mineralization of the vessel wall, is frequently associated with aging, atherosclerosis, diabetes mellitus, and chronic kidney disease. Vascular calcification is a key risk factor for many adverse clinical outcomes, including ischemic cardiac events and subsequent cardiovascular mortality. Vascular calcification was long considered to he a passive degenerative process, but it is now recognized as an active and highly regulated process similar to bone formation. However, despite numerous studies on the pathogenesis of vascular calcification, the mechanisms driving this process remain poorly understood. Pyruvate dehydrogenase kinases (PDKs) play an important role in the regulation of cellular metabolism and mitochondria' function. Recent studies show that PDK4 is an attractive therapeutic target for the treatment of various metabolic diseases. In this review, we summarize our current knowledge regarding the mechanisms of vascular calcification and describe the role of PDK4 in the osteogenic differentiation of vascular smooth muscle cells and development of vascular calcification. Further studies aimed at understanding the molecular mechanisms of vascular calcification will be critical for the development of novel therapeutic strategies.
引用
收藏
页码:52 / 61
页数:10
相关论文
共 97 条
  • [91] Mitochondrial DNA Damage Can Promote Atherosclerosis Independently of Reactive Oxygen Species Through Effects on Smooth Muscle Cells and Monocytes and Correlates With Higher-Risk Plaques in Humans
    Yu, Emma
    Calvert, Patrick A.
    Mercer, John R.
    Harrison, James
    Baker, Lauren
    Figg, Nichola L.
    Kumar, Sheetal
    Wang, Julie C.
    Hurst, Liam A.
    Obaid, Daniel R.
    Logan, Angela
    West, Nick E. J.
    Clarke, Murray C. H.
    Vidal-Puig, Antonio
    Murphy, Michael P.
    Bennett, Martin R.
    [J]. CIRCULATION, 2013, 128 (07) : 702 - 712
  • [92] Mitochondria in vascular disease
    Yu, Emma
    Mercer, John
    Bennett, Martin
    [J]. CARDIOVASCULAR RESEARCH, 2012, 95 (02) : 173 - 182
  • [93] Matrix GLA protein, a regulatory protein for bone morphogenetic protein-2
    Zebboudj, AF
    Imura, M
    Boström, K
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (06) : 4388 - 4394
  • [94] The pivotal role of pyruvate dehydrogenase kinases in metabolic flexibility
    Zhang, Shuai
    Hulver, Matthew W.
    McMillan, Ryan P.
    Cline, Mark A.
    Gilbert, Elizabeth R.
    [J]. NUTRITION & METABOLISM, 2014, 11
  • [95] Mitochondrial reactive oxygen species promote p65 nuclear translocation mediating high-phosphate-induced vascular calcification in vitro and in vivo
    Zhao, Ming-Ming
    Xu, Ming-Jiang
    Cai, Yan
    Zhao, Gexin
    Guan, Youfei
    Kong, Wei
    Tang, Chaoshu
    Wang, Xian
    [J]. KIDNEY INTERNATIONAL, 2011, 79 (10) : 1071 - 1079
  • [96] Osteoprotegerin Inhibits Calcification of Vascular Smooth Muscle Cell via Down Regulation of the Notch1-RBP-Jκ/Msx2 Signaling Pathway
    Zhou, Shaoqiong
    Fang, Xing
    Xin, Huaping
    Li, Wei
    Qiu, Hongyu
    Guan, Siming
    [J]. PLOS ONE, 2013, 8 (07):
  • [97] Novel cardiovascular risk factors in end-stage renal disease
    Zoccali, C
    Mallamaci, F
    Tripepi, G
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (01): : S77 - S80